UCLA researchers develop therapy to treat PTSD, depression

January 28, 2016
Veteran Ron Ramirez discusses the trigeminal nerve stimulation neuromodulation device with Andrew Leuchter, director of the Neuromodulation Division at UCLA Semel Institute for Neuroscience and Human Behavior and a psychiatry professor.
Veteran Ron Ramirez discusses the trigeminal nerve stimulation neuromodulation device with Andrew Leuchter, director of the Neuromodulation Division at UCLA Semel Institute for Neuroscience and Human Behavior and a psychiatry professor.
CalFoto

Research conducted by Andrew Leuchter (Semel Institute for Neuroscience and Human Behavior, department of Psychiatry and Biobehavioral Science) and David Geffen School of Medicine’s  Ian Cook (department of Psychiatry and Biobehavioral Sciences) and Christopher DeGiogio (department of Neurology) is currently underway to figure out the effectiveness of the NeuroSigma Inc. electric patch, a box about the size of a deck of cards. Patients can use it to self-administer trigeminal nerve stimulation, or TNS. The therapy has been proven to significantly reduce symptoms in veterans with PTSD and major depressive disorders.

Read more at Daily Bruin